Lenka Hruba

Affiliations: 
Pharmacology University of Texas Health Science Center - San Antonio 
Google:
"Lenka Hruba"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hruba L, McMahon LR. (2017) Apparent affinity estimates and reversal of the effects of synthetic cannabinoids AM-2201, CP-47,497, JWH-122, and JWH-250 by rimonabant in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics
Ghosh S, Kinsey SG, Liu QS, et al. (2015) Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice. The Journal of Pharmacology and Experimental Therapeutics. 354: 111-20
Hruba L, Seillier A, Zaki A, et al. (2015) Simultaneous inhibition of fatty acid amide hydrolase and monoacylglycerol lipase shares discriminative stimulus effects with Δ9-tetrahydrocannabinol in mice. The Journal of Pharmacology and Experimental Therapeutics. 353: 261-8
Ginsburg BC, Hruba L, Zaki A, et al. (2014) Blood levels do not predict behavioral or physiological effects of Δ⁹-tetrahydrocannabinol in rhesus monkeys with different patterns of exposure. Drug and Alcohol Dependence. 139: 1-8
Hruba L, McMahon LR. (2014) The cannabinoid agonist HU-210: pseudo-irreversible discriminative stimulus effects in rhesus monkeys. European Journal of Pharmacology. 727: 35-42
Hruba L, Ginsburg BC, McMahon LR. (2012) Apparent inverse relationship between cannabinoid agonist efficacy and tolerance/cross-tolerance produced by Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics. 342: 843-9
Ginsburg BC, Schulze DR, Hruba L, et al. (2012) JWH-018 and JWH-073: Δ⁹-tetrahydrocannabinol-like discriminative stimulus effects in monkeys. The Journal of Pharmacology and Experimental Therapeutics. 340: 37-45
See more...